Sign in

CIK 0001737953

  • Non-accelerated filer
  • Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
822082553
Phone
+1 781-222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$521,860
in 2 filings

Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dhingra Kapil −$409K Director sold 50% of stake
  2. SLATTERY JOSEPH P −$113K Director sold 78% of stake

Reading 83 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-10 Patel Sushil Chief Executive Officer Sale −39,341 $12.97 $510K 708,151
2026-05-18 Patel Sushil Chief Executive Officer Sale −37,324 $5.08 $190K 747,492
2026-04-01 Patel Sushil Chief Executive Officer Grant or award +251,240 784,816
2026-04-01 Patel Sushil Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +376,860 376,860
2025-12-19 Patel Sushil Chief Executive Officer Grant or award +200,000 533,576
2025-12-02 Patel Sushil Chief Executive Officer Sale 10b5-1 −10,000 $11.13 $111K 333,576
2025-05-20 Patel Sushil Chief Executive Officer Sale −25,105 $8.06 $202K 343,576
2025-04-01 Patel Sushil Chief Executive Officer Grant or award +166,667 368,681
2025-04-01 Patel Sushil Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +250,000 250,000
2024-12-16 Patel Sushil Chief Executive Officer Sale 10b5-1 −10,000 $12.42 $124K 202,014
2024-05-16 Patel Sushil Chief Executive Officer Sale −20,194 $6.47 $131K 212,014
2024-04-01 Patel Sushil Chief Executive Officer Grant or award +83,335 232,208
2024-04-01 Patel Sushil Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +250,000 250,000
2023-06-13 Patel Sushil Chief Strategy Officer Sale 10b5-1 −5,145 $24.11 $124K 149,426
2023-06-13 Patel Sushil Chief Strategy Officer Sale 10b5-1 −553 $23.44 $13K 148,873
2023-05-16 Patel Sushil Chief Strategy Officer Sale −15,575 $18.05 $281K 154,571
2023-04-01 Patel Sushil Chief Strategy Officer Grant or award +40,000 170,146
2023-04-01 Patel Sushil Chief Strategy Officer Grant or award · Employee Stock Option (right to buy) +60,000 60,000
2022-05-16 Patel Sushil Chief Commercial Officer Sale −10,687 $14.59 $156K 130,146
2022-04-01 Patel Sushil Chief Commercial Officer Grant or award +52,500 140,833

Page 1 of 2 · 23 trades